Clinical Trials Logo

Renal Stones clinical trials

View clinical trials related to Renal Stones.

Filter by:

NCT ID: NCT06175910 Completed - Renal Stones Clinical Trials

Postoperative Outcomes of PCNL vs RIRS in Obese Patients With Pelvic 1.5:3 cm Renal Stones

PCNL VS RIRS
Start date: December 2, 2020
Phase: N/A
Study type: Interventional

This prospective randomized comparative study was done at Helwan University Hospital. It was conducted on 120 patients with unilateral pelvic renal stones from 1.5 to 3 cm in largest diameter who was admitted through duration to compare the two procedures differences in terms of complications, analgesic use, hospital stay, operational time, and stone-free rates.

NCT ID: NCT06120257 Completed - Renal Stones Clinical Trials

Management of Lower Pole Renal Hard Stones ≤2 cm

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The study has been conducted in Urology department at Kafrelsheikh University Hospital between March 2022 to March 2023. informed consent was taken from eligible patients and were randomized into three groups, Group A :Flexible ureteroscope (F-URS) group underwent holmium laser lithotripsy using flexible ureteroscopy (Boston® scientific (lithovue) while, Group B : extracorporeal shock wave lithotripsy (ESWL) group underwent electromagnetic extracorporeal shock wave lithotripsy (STORZ® MEDICAL Modulith SLX-F2 FD21, Germany) .Group C : Mini perc group underwent holmium laser lithotripsy using Karl® Storz MIP set.

NCT ID: NCT05855057 Completed - Clinical trials for Ultrasound Therapy; Complications

Effectiveness of US-Guided PCNL Different Positions in Renal Stones Treatment

Start date: January 20, 2018
Phase:
Study type: Observational

The aim of this study is to compare the effectiveness of Ultrasound-Guided Percutaneous nephrolithotomyin different positions supine, prone positions and flank suspend supine position in renal stones treatment.

NCT ID: NCT04578795 Active, not recruiting - Renal Stones Clinical Trials

Effectiveness of Single Use Flexible Ureteroscopes in Treatment of Renal Stones

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

To study the Effectiveness of single use flexible Ureteroscopes in treatment of renal stones

NCT ID: NCT04367155 Recruiting - Nephrolithiasis Clinical Trials

Efficacy of Tranexamic Acid on Blood Loss During Percutaneous Nephrolithotomy.

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

Efficacy of tranexamic acid on blood loss during percutaneous nephrolithotomy. a double-blind, placebo-controlled randomized clinical trial.

NCT ID: NCT04345835 Completed - Renal Stones Clinical Trials

Prone Flexed Position in Percutanous Nephrolithotomy

Start date: April 1, 2018
Phase: N/A
Study type: Interventional

prone flexed position in percutanous nephrolithotomy in comparsion with standard prone position. A randomized controlled trial.

NCT ID: NCT03924596 Not yet recruiting - Renal Stones Clinical Trials

Treatment of Renal Stones With Frankincense (Luban)

Luban
Start date: September 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Frankincense, or olibanum, is the oleogum resin that is harvested from several different trees, an aromatic resin obtained from trees of the genus Boswellia. The word frankincense is derived from the ancient French name "frankincense," meaning "pure incense." Frankincense is also known in Arabic as "luban,". Luban has been reported to have anti-inflammatory, sedative, antibacterial, and anti-cancer activities. The aim of the present study is to treat renal stones with Luban (Boswellia) given as capsules of active oils. This is a clinical Phase I & II (Safety, Efficacy) double-blind simple-randomized controlled treatment trial, where 100 participants with renal stones (50 Radiopaque and 50 Radiolucent stones) will be included in the study and divided between two treatment groups: Standard treatment (Uralyt-U) and new treatment (Luban). Participants with stone size less than 10 mm will be include; and participants with renal pathology or comorbidities (DM, CKD, multiple renal cysts, renal tumors) will be excluded. The outcome measures of the study will be: the primary end point (effect) is reduction of stone size by 50% or complete disappearance after 1 years of treatment; and the secondary end point (toxicity) is the participants intolerance of the treatment or development of side effects. If this study proves an effect of Luban on renal stones it will be an evolution in the management of renal stones by a natural, simple, harmless easily available method.

NCT ID: NCT03795532 Recruiting - Renal Stones Clinical Trials

Ultraslow SWL Versus Slow SWL for Renal Stones With High Attenuation Value

ESWL
Start date: January 11, 2019
Phase: N/A
Study type: Interventional

Ultraslow full-power SWL versus slow power-ramping SWL in Renal stones with high attenuation value

NCT ID: NCT03763539 Completed - Renal Stones Clinical Trials

Ultraslow Full-power SWL Versus Slow Power-ramping SWL in Stones With High Attenuation Value

SWL
Start date: September 2015
Phase: N/A
Study type: Interventional

Ultraslow full-power SWL versus slow power-ramping SWL in stones with high attenuation value

NCT ID: NCT02658942 Completed - Renal Stones Clinical Trials

Flexible Ureteroscopy Versus ESWL in the Management of Lower Calyceal Stones

Start date: May 2010
Phase: N/A
Study type: Interventional

to assess safety, efficacy of Flexible ureteroscopy (FURS) holmium:YAG laser lithotripsy (LL) compared to extracorporeal shockwave lithotripsy (ESWL) in management of lower calyceal stones (LC) stones.